To further understand WTH3's involvement in MDR, we carried out shRNA knockdown experiments to see if reduced WTH3 expression would increase tolerance of host cells to the anti-cancer drug, Doxorubicin (Dox). The gene discussed is RAB6C; the disease is cancer.